Objective: The achievement of single vessel inflow to the wound is an acceptable end point of peripheral vascular intervention for patients with critical limb ischemia (CLI) with tissue loss. However, CLI patients often have multitibial artery lesions. We evaluated the clinical effects of single or double tibial artery revascularization for CLI patients.
Critical limb ischemia (CLI) represents the most advanced stage of peripheral artery disease and has a high risk of major amputation and death. 1 Peripheral vascular intervention (PVI) has been established as an acceptable therapy for CLI based on comparable clinical outcomes with bypass surgery. 2, 3 However, a high restenosis rate remains a major problem of PVI for infrapopliteal disease of CLI patients. 4, 5 Achieving single vessel inflow to the wound is an acceptable end point of PVI for CLI with tissue loss. In daily practice, CLI patients often have significant lesions in both the anterior tibial artery (ATA) and the posterior tibial artery (PTA). In such cases, it remains to be clarified how the additional revascularization of the other tibial artery after achieving single vessel inflow in one tibial artery to the wound would affect wound healing. This study aimed to clarify whether the revascularization of both the ATA and the PTA improves clinical outcomes compared with single artery revascularization (either ATA or PTA) in CLI patients with tissue loss who have lesions in both the ATA and the PTA.
METHODS
Patient population. The patient selection and enrollment flow chart is shown in Fig 1. This study was conducted retrospectively in a single center. A total of 244 CLI patients with tissue loss (268 limbs) with infrapopliteal lesions underwent PVI in our hospital between April 2007 and January 2015. Among these patients, 197 limbs had a lesion in both the ATA and the PTA, and 151 limbs had at least single vessel inflow to the wound (the technical success rate was 77% [151/197] ). After the exclusion of 14 limbs with only a peroneal artery (PA) flow to the wound, 137 limbs with at least single vessel inflow to the wound of the ATA or PTA or both were included in this study. Of these, single tibial artery (ATA or PTA) revascularization was successfully achieved in 84 limbs (group S; Fig 2, A) and double tibial artery revascularization (both ATA and PTA) was successfully achieved in 53 limbs (group D ; Fig 2, B) . The study protocol was in accordance with the Declaration of Helsinki and approved by the institutional review board of our hospital. Informed consent to undergo the procedure was obtained from all the patients.
Patient evaluation and procedure. CLI with tissue loss was defined according to the Trans-Atlantic Inter-Society Consensus guidelines as tissue loss associated with an absolute ankle pressure of less than 50 mm Hg or a toe pressure of less than 30 mm Hg. 2 The skin perfusion pressure (SPP) was measured and an SPP of less than 40 mm Hg was considered to indicate ischemic tissue loss when the ankle or toe pressure could not be measured because of pain or severely calcified arteries. 6 All wounds were recorded photographically on admission and their hemodynamic status was evaluated using the ankle-brachial pressure index, SPP, and duplex ultrasound examination. Infectious status was carefully assessed, and myelitis or subcutaneous abscess was investigated using magnetic resonance imaging or duplex ultrasound. Texas grade was used to evaluate wound depth. 7 The overall severity of CLI was assessed using the Society for Vascular Surgery (SVS) Wound, Ischemia, and foot Infection (WIfI) classification system, and each limb was assigned a clinical stage (1-4). 8 The indication for bypass surgery was discussed with a vascular surgeon in consideration of the patient's general condition and the condition of the vessels for bypass connection. If both treatments were possible, we selected PVI as the first therapy. All aortoiliac disease and femoropopliteal disease were treated by PVI at the same time as the treatment by infrapopliteal PVI or before the infrapopliteal PVI at the operator's discretion. For infrapopliteal PVI, initially, we attempted to open the ATA or PTA, which was a direct source of blood based on the angiosome concept and attempted to achieve visible blood flow to the wound. However, when revascularization based on the angiosome concept proved difficult, we obtained an indirect blood flow to the wound. Our PVI end point was to achieve at least single vessel inflow to the wound, regardless of the angiosome concept. Thereafter, the other tibial artery (ATA or PTA) was opened at the operator's discretion and another vessel inflow to the wound was achieved. After the infusion of 5000 U of heparin, an 0.014-inch guidewire was used to cross the lesion, and only balloon angioplasty was carried out after the wire crossing of the lesion of the tibial artery. Dual antiplatelet therapy with 100 mg/d aspirin and either 200 mg/d ticlopidine or 75 mg/d clopidogrel was started at least 1 week before the procedure and continued for at least 1 month thereafter.
Follow-up and wound care. All patients were followed once or twice a week at our outpatient foot care clinic. Interventional cardiologists, a plastic surgeon, nurses with specialized foot care training, and a prosthetist composed our foot care team. Wounds were photographed each time and their healing process was followed. Wound healing was assessed based on the Tissue, Infection or Inflammation, Moisture imbalance, and Edge of wound (TIME) classification. 9 Our management included wound cleaning, ointment application, wound debridement, education of patients and families regarding daily care of wounds, and evaluation of blood flow to wounds as necessary. Off-loading techniques were also undertaken, using customized shoes for depressurization. Infected wounds were treated with appropriate antibiotics, and if the infection was not resolved sufficiently, myelitis or subcutaneous abscesses was investigated using magnetic resonance imaging or duplex ultrasound imaging. The plastic surgeon decided the indications for incisional drainage, ostectomy, and auto skin graft. The ankle-brachial pressure index and SPP were obtained every 3 months and, if the wound healing course was insufficient, target vessel restenosis was evaluated using duplex ultrasound imaging or angiography. We performed repeat PVI when target vessel restenosis was considered as the cause of delays in Representative cases of groups S and D. A, Before peripheral vascular intervention (PVI), both the anterior tibial artery (ATA) and the posterior tibial artery (PTA) had lesions, and single-artery revascularization (ATA only) was performed by PVI. Single-vessel inflow to the wound was achieved. B, Before PVI, both the ATA and the PTA had lesions, and both ATA and PTA were treated by PVI. Double-vessel inflows to the wound were achieved.
wound healing. If repeat PVI failed to achieve sufficient direct blood supply to the wounds, the indication for bypass surgery was revisited.
End points. The primary end point was the wound healing rate at 1 year. The secondary end points included the (1) time to wound healing in only a healed wound, (2) repeat revascularization rate before achievement of wound healing in only a healed wound, (3) limb salvage rate at 3 years, and (4) amputation-free survival rate at 3 years. In the subanalysis, wound healing was compared according to the CLI severity as evaluated using the SVS WIfI classification.
Definitions. Limb salvage was defined as freedom from major amputation, which included any amputation above the ankle. Any amputation below the ankle was defined as a minor amputation. We defined wounds as completely healed when 100% epithelialization of tissue loss was obtained, and any wound care, including cleaning and application of ointment, became unnecessary. Good pedal arch flow was defined as arterial flow through one of the main pedal arteries (dorsalis pedis, common plantar) reaching the main contralateral pedal artery through the connection via the deep penetrating artery. 10 Coronary artery disease was regarded as documented angina pectoris, previous myocardial infarction, or a history of percutaneous coronary intervention. Cerebrovascular disease was regarded as involving a previous stroke, transient ischemic attacks, carotid artery revascularization, or intracranial hemorrhage. Diabetes mellitus was defined as treatment with insulin or oral hypoglycemic drugs, or a casual plasma glucose level of greater than 200 mg/dL or hemoglobin A 1 c of greater than 6.5%. Heart failure was defined as a history of hospitalization owing to heart failure or current treatment for heart failure.
Statistical analysis. Categorical variables were presented as counts and percentages, and continuous variables were presented as mean values 6 standard deviations. Categorical variables were compared using the Fisher exact test or c 2 test. Continuous variables with or without normal distributions were compared using either the unpaired t-test or the Mann-Whitney U test. End point and survival analyses were performed using Kaplan-Meier estimates. Univariate and multiple Cox proportional hazard analyses were used to identify the predictors of wound healing at 1 year. Each variable with P < .05 by univariate analysis was included in the stepwise multiple Cox proportional hazard model. A two-sided P < .05 was considered to indicate a statistically significant difference. All analyses were performed using SPSS software (version 19; IBM, Somers, NY).
RESULTS
Baseline characteristics. Table I provides a summary of the baseline patient characteristics. There was no differences in the baseline characteristics between the two groups in terms of age, sex, risk factors, laboratory data, and antiplatelet drug regimen. Table II shows the lesion and wound characteristics of groups S and D. The prevalence rates of aortoiliac disease (6% in group S and 6% in group D; P ¼ .94) and femoropopliteal disease (42% in group S and 28% in group D; P ¼ .11) were not different between the groups. Both groups had lesions in the ATA and the PTA. The prevalence of a PA lesion was 80% in group S and 72% in group D (P ¼ .28). Chronic total occlusion and severe calcification were similarly included in both groups. Regarding wound characteristics, the prevalences of Rutherford stage 6, gangrene, and infection were not different between the two groups. There were no differences in the wound location and depth between the two groups. The clinical stage assessed using the SVS WIfI classification was also not different between the two groups. The percentage need for skin Results of intervention. Table III shows the results of the intervention for the two groups. In group S, the ATA was treated successfully in 67% of patients and the PTA in 33%. Revascularization based on the angiosome concept was achieved in 62% in group S and 100% in group D (P < .001). The prevalences of PA flow and a good pedal arch were not different between the two groups (PA flow: 52% vs 59% [P ¼ .48]; good pedal arch: 64% vs 79% [P ¼ .06]). A distal tibial puncture was performed in 11% of patients in group S and 4% in group D (P ¼ .15). The transcollateral approach was performed in 7% of patients in group S and 4% in group D (P ¼ .41). The ankle-brachial pressure index and SPP after the procedure were similarly improved in both groups.
Outcome measures. The wound healing rate at 1 year was significantly higher in group D than in group S (87% vs 79%; log-rank, P ¼ .003 ; Fig 3, A) Fig 3, B) . The repeat PVI rate before achievement of wound healing was significantly lower in group D than in group S (15% vs 35%; P ¼ .03 ;  Fig 3, C) . Reintervention was performed in the same segment of the initial PVI in 92% of lesions, and the technical success rate of the repeat PVI was 96%. The limb salvage rate at 3 years was not different between the two groups (94% vs 86%; log-rank, P ¼ .18; Fig 4) . The amputation-free survival rate at 3 years tended to be higher in group D than in group S (62% vs 50%; log-rank, P ¼ .10; Fig 5) . (Table IV) . Good pedal arch flow was not a significant predictor of wound were independent predictors of wound healing at 1 year (Table IV) . Effect of double tibial artery revascularization according to clinical stage severity. The wound healing rate at 1 year was not different between the two groups only in wounds at clinical stage 1 or 2 (93% group S vs 90% group D; log-rank, P ¼ .20; Fig 6, A) . However, the wound healing rate at 1 year was significantly higher in group D than in group S in only wounds at clinical stage 3 or 4 (72% group S vs 85% group D; log-rank, P ¼ .007; Fig 6, B) .
DISCUSSION
The important findings of this study are that (1) the revascularization of both the ATA and the PTA was superior to the revascularization of a single tibial artery for wound healing, (2) only in a healed wound, the time to wound healing was significantly shorter and the repeat PVI rate was significantly lower in CLI patients in whom both the ATA and the PTA were treated than in CLI patients in whom a single tibial artery (ATA or PTA) was treated, (3) the revascularization of both the ATA and the PTA was an independent predictor that positively affected wound healing, and (4) the effect of the revascularization of both the ATA and the PTA on wound healing was more significant in a severe CLI status as assessed using the SVS WIfI classification system. There has been a continuing argument regarding the optimal end point of revascularization by infrapopliteal PVI to obtain optimal clinical outcomes for CLI patients with tissue loss. Revascularization based on the angiosome concept has been reported to be associated with better outcomes of CLI patients, 11, 12 although negative findings have also been reported. 13, 14 In their systematic review, Sumpio et al 14 emphasized the limited data on the clinical relevance of the angiosome concept because of the retrospective fashion, low technical feasibility, and heterogeneous population of the patients in previous studies. A well-structured prospective study is needed to evaluate definitively the importance of the angiosome concept. In the present study, multivariate analysis showed no independent association between revascularization based on the angiosome concept and wound healing. Previous reports suggest that an indirect flow of blood to the wound is associated with improvement of outcomes in CLI patients; therefore, revascularization of both the ATA and the PTA is potentially associated with a much better clinical outcome in CLI patients with tissue loss than single tibial revascularization. Kawarada et al 15 demonstrated that single tibial revascularization (ATA or PTA) improved the microcirculation when similarly evaluated by SPP measurement in both the dorsal and plantar foot. Angiographic restenosis was reportedly observed in 73% of lesions in CLI patients 3 months after infrapopliteal angioplasty. 4 Wound healing progresses when there is sufficient blood supply to the wound, but the course of wound healing is disturbed when restenosis occurs and the blood supply becomes insufficient. A major tissue loss requires more time to achieve wound healing than a minor tissue loss. 16 Therefore, a low restenosis rate and late restenosis timing brought about by having more vessel inflows to the wound are important for achieving a good wound healing course. Achieving double vessel inflows to the wound by revascularization of both the ATA and the PTA is beneficial for wound healing because of the lower possibility of restenosis of both tibial arteries than by the revascularization of a single tibial artery. In the present study, we demonstrated a lower requirement for repeat PVI, a shorter time to wound healing, and a significantly higher wound healing rate in patients with double tibial artery revascularization than in patients with single tibial artery revascularization.
The clinical impact of a good pedal arch has been reported previously. 10, 17, 18 However, we believe that revascularization to achieve a good pedal arch is not similar to revascularization of both the ATA and the PTA to achieve double vessel inflows to the wound. For effective treatment, it is more important to increase the blood flow source to the wound than to make a pedal artery loop. Even in the absence of an apparent pedal artery loop, achievement of double vessel inflows to the wound after revascularization of both the ATA and the PTA seems to have a greater effect on the clinical improvement of CLI patients. In the present study, 64% and 79% had a good pedal artery in groups S and D, respectively. The presence of a good pedal arch was not shown to be an independent predictor of wound healing by multivariate analysis. We believe that obtaining blood flow to the wound via the dorsal artery and the plantar artery is a more important factor in achieving successful treatment than the presence of a pedal arch. We also suggest that the optimal end point may differ according to the severity of the CLI. Recently, the SVS Lower Extremity Guidelines Committee has established the WIfI classification system to stratify the risk of amputation in CLI patients. 8 In addition, the predictive ability of severe, the needed blood supply to the wound becomes greater. The present results support these findings. The clinical effect of revascularization of both the ATA and the PTA was greater, particularly in clinical stage 3 or 4 patients. The SVS WIfI classification system was a useful tool for risk stratification and decision making regarding whether additional tibial artery revascularization can improve wound healing.
Study limitations. First, the sample size of the present study was relatively small and the study design was retrospective in nature. In the future, a prospective randomized study with sufficient sample size should be performed to definitively confirm the present findings. Second, additional revascularization depended on the operator's discretion; therefore, selection bias cannot be excluded completely. Third, only balloon angioplasty was performed for infrapopliteal intervention because balloon angioplasty was the only option available in Japan during the study period. A drug-coated balloon 21 and a drug-eluting stent 22 have been shown to reduce the restenosis rate compared with conventional percutaneous transluminal angioplasty. The use of these devices may affect the outcomes. Finally, we excluded CLI patients who underwent bypass surgery. However, bypass surgery is superior to PVI with respect to providing sufficient blood supply to distal tissue. The single vessel inflow to the wound achieved by bypass surgery and that achieved by PVI were considered as different; therefore, we included patients who underwent PVI alone to definitively evaluate whether the additional tibial revascularization by PVI was important or not.
CONCLUSIONS
Traditionally, the achievement of single vessel inflow to the wound has been considered as an acceptable end point of infrapopliteal PVI for CLI patients with tissue loss. However, additional revascularization of the other tibial artery was found to be beneficial in terms of wound healing. The achievement of double vessel inflows to the wound was shown to be associated with a lower rate of repeat PVI and a shorter time to wound healing than the achievement of single vessel inflow to the wound. Furthermore, the clinical effect of double vessel inflows to the wound was much greater according to CLI severity, as assessed by the SVS WIfI score. In daily practice, it is occasionally difficult to achieve success in double tibial artery revascularization because of lesion severity. However, as the CLI status becomes severe, double vessel inflows to the wound should be attempted to obtain a higher wound healing rate, a lower repeat PVI rate, and a shorter time to wound healing.
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